Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
The new capital is expected to fund the company through 2029
ALV-100 is a bifunctional fusion protein combining glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonism with glucagon-like peptide-1 receptor agonism
Bloom has pioneered a technology to transform plant waste into valuable chemical products
The freshly infused capital will primarily be deployed towards expansion and research & development
A funding to expand operations and provide better patient care
The funding round also saw participation from some of India's top angel investors and leading industry giants
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Subscribe To Our Newsletter & Stay Updated
